News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Features Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks Caitlin E. Cox February 03, 2023
News Features From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine L.A. McKeown October 18, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Features As US Cardiologists Mull a Biden Presidency, COVID-19 Trumps All Todd Neale November 13, 2020
News Features Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability Todd Neale May 08, 2020
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features Year in Review: Physicians Pick the Biggest News of 2018 TCTMD News Team December 29, 2018
News Features How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts Michael O'Riordan May 23, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity Yael L. Maxwell October 24, 2016
News Features Requiem for a Heavyweight: Big Brand Statin Era Comes to a Close as Crestor Heads Off-Patent Michael O'Riordan May 03, 2016
News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016
News Features Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices Yael L. Maxwell June 27, 2014